<p>In a study led by investigators from <a href="https://www.massgeneralbrigham.org/" target=" blank">Mass General Brigham</a>, <a href="https://wyss.harvard.edu/" target=" blank">the Wyss Institute for Biologically Inspired Engineering at Harvard University</a> and <a href="https://www.dana-farber.org/" target=" blank">Dana-Farber Cancer Institute</a>, in collaboration with researchers from across the country and beyond the U.S., researchers developed a low-cost, ultrasensitive blood test to detect minute levels of a cancer biomarker that is highly specific to multiple common cancers. Each test can be performed with merely half a drop of blood (25 microliters). The tool showed promise for early cancer detection and disease monitoring, and could potentially be used in conjunction with other tools for detection, risk stratification and treatment. Results are published in <a href=&quo
Pan-Cancer Biomarker Detected by Ultrasensitive Blood Test miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Miniature antibodies called nanobodies, derived from llamas, have demonstrated therapeutic potential in the fight against Covid and its variants, according to a study.Amid the growing threat of Omicron - the new and potentially more dangerous .
A new study published in <i>eLife</i> demonstrates the therapeutic potential of nanobodies – miniature antibodies derived from llamas – against SARS-CoV-2.
New York, Dec 8 (IANS) Miniature antibodies called nanobodies, derived from llamas, have demonstrated therapeutic potential in the fight against Covid and its